Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Physiol Res ; 67(Suppl 4): S601-S610, 2018 12 31.
Artículo en Inglés | MEDLINE | ID: mdl-30607967

RESUMEN

Cardiac resynchronization therapy (CRT) has proven efficacious in the treatment of patients with heart failure and dyssynchronous activation. Currently, we select suitable CRT candidates based on the QRS complex duration (QRSd) and morphology with left bundle branch block being the optimal substrate for resynchronization. To improve CRT response rates, recommendations emphasize attention to electrical parameters both before implant and after it. Therefore, we decided to study activation times before and after CRT on the body surface potential maps (BSPM) and to compare thus obtained results with data from electroanatomical mapping using the CARTO system. Total of 21 CRT recipients with symptomatic heart failure (NYHA II-IV), sinus rhythm, and QRSd >/=150 ms and 7 healthy controls were studied. The maximum QRSd and the longest and shortest activation times (ATmax and ATmin) were set in the BSPM maps and their locations on the chest were compared with CARTO derived time interval and site of the latest (LATmax) and earliest (LATmin) ventricular activation. In CRT patients, all these parameters were measured during both spontaneous rhythm and biventricular pacing (BVP) and compared with the findings during the spontaneous sinus rhythm in the healthy controls. QRSd was 169.7+/-12.1 ms during spontaneous rhythm in the CRT group and 104.3+/-10.2 ms after CRT (p<0.01). In the control group the QRSd was significantly shorter: 95.1+/-5.6 ms (p<0.01). There was a good correlation between LATmin(CARTO) and ATmin(BSPM). Both LATmin and ATmin were shorter in the control group (LATmin(CARTO) 24.8+/-7.1 ms and ATmin(BSPM) 29.6+/-11.3 ms, NS) than in CRT group (LATmin(CARTO) was 48.1+/-6.8 ms and ATmin(BSPM) 51.6+/-10.1 ms, NS). BVP produced shortening compared to the spontaneous rhythm of CRT recipients (LATmin(CARTO) 31.6+/-5.3 ms and ATmin(BSPM) 35.2+/-12.6 ms; p<0.01 spontaneous rhythm versus BVP). ATmax exhibited greater differences between both methods with higher values in BSPM: in the control group LATmax(CARTO) was 72.0+/-4.1 ms and ATmax (BSPM) 92.5+/-9.4 ms (p<0.01), in the CRT candidates LATmax(CARTO) reached only 106.1+/-6.8 ms whereas ATmax(BSPM) 146.0+/-12.1 ms (p<0.05), and BVP paced rhythm in CRT group produced improvement with LATmax(CARTO) 92.2+/-7.1 ms and ATmax(BSPM) 130.9+/-11.0 ms (p<0.01 before and during BVP). With regard to the propagation of ATmin and ATmax on the body surface, earliest activation projected most often frontally in all 3 groups, whereas projection of ATmax on the body surface was more variable. Our results suggest that compared to invasive electroanatomical mapping BSPM reflects well time of the earliest activation, however provides longer time-intervals for sites of late activation. Projection of both early and late activated regions of the heart on the body surface is more variable than expected, very likely due to changed LV geometry and interposed tissues between the heart and superficial ECG electrode.


Asunto(s)
Mapeo del Potencial de Superficie Corporal/tendencias , Bloqueo de Rama/fisiopatología , Bloqueo de Rama/terapia , Terapia de Resincronización Cardíaca/tendencias , Electrocardiografía/tendencias , Adulto , Anciano , Mapeo del Potencial de Superficie Corporal/métodos , Bloqueo de Rama/diagnóstico , Terapia de Resincronización Cardíaca/métodos , Electrocardiografía/métodos , Fenómenos Electrofisiológicos/fisiología , Femenino , Sistema de Conducción Cardíaco/fisiopatología , Insuficiencia Cardíaca/diagnóstico , Insuficiencia Cardíaca/fisiopatología , Insuficiencia Cardíaca/terapia , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
2.
Physiol Res ; 66(Suppl 4): S523-S528, 2017 12 30.
Artículo en Inglés | MEDLINE | ID: mdl-29355380

RESUMEN

Cardiac resynchronization therapy (CRT) has proven efficacious in reducing or even eliminating cardiac dyssynchrony and thus improving heart failure symptoms. However, quantification of mechanical dyssynchrony is still difficult and identification of CRT candidates is currently based just on the morphology and width of the QRS complex. As standard 12-lead ECG brings only limited information about the pattern of ventricular activation, we aimed to study changes produced by different pacing modes on the body surface potential maps (BSPM). Total of 12 CRT recipients with symptomatic heart failure (NYHA II-IV), sinus rhythm and QRS width >/=120 ms and 12 healthy controls were studied. Mapping system Biosemi (123 unipolar electrodes) was used for BSPM acquisition. Maximum QRS duration, longest and shortest activation times (ATmax and ATmin) and dispersion of QT interval (QTd) were measured and/or calculated during spontaneous rhythm, single-site right- and left-ventricular pacing and biventricular pacing with ECHO-optimized AV delay. Moreover we studied the impact of CRT on the locations of the early and late activated regions of the heart. The average values during the spontaneous rhythm in the group of patients with dyssynchrony (QRS 140.5+/-10.6 ms, ATmax 128.1+/-10.1 ms, ATmin 31.8+/-6.7 ms and QTd 104.3+/-24.7 ms) significantly differed from those measured in the control group (QRS 93.0+/-10.0 ms, ATmax 79.1+/-3.2 ms, ATmin 24.4+/-1.6 ms and QTd 43.6+/-10.7 ms). Right ventricular pacing (RVP) improved significantly only ATmax [111.2+/-10.6 ms (p<0.05)] but no other measured parameters. Left ventricular pacing (LVP) succeeded in improvement of all parameters [QRS 105.1+/-8.0 ms (p<0.01), ATmax 103.7+/-7.1 ms (p<0.01), ATmin 20.2+/-3.7 ms (p<0.01) and QTd 52.0+/-9.4 ms (p<0.01)]. Biventricular pacing (BVP) showed also a beneficial effect in all parameters [QRS 121.3+/-8.9 ms (p<0.05), ATmax 114.3+/-8.2 ms (p<0.05), ATmin 22.0+/-4.1 ms (p<0.01) and QTd 49.8+/-10.0 ms (p<0.01)]. Our results proved beneficial outcome of LVP and BVP in evaluated parameters (what seems to be important particularly in the case of activation times) and revealed a complete return of activation times to normal distribution when using these CRT modalities.


Asunto(s)
Terapia de Resincronización Cardíaca/métodos , Electrocardiografía/métodos , Insuficiencia Cardíaca/fisiopatología , Insuficiencia Cardíaca/terapia , Anciano , Terapia de Resincronización Cardíaca/tendencias , Electrocardiografía/tendencias , Femenino , Insuficiencia Cardíaca/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Resultado del Tratamiento
3.
Ceska Gynekol ; 81(1): 38-40, 2016 Jan.
Artículo en Checo | MEDLINE | ID: mdl-26982063

RESUMEN

OBJECT: Describing the course of pregnancy and perinatal outcomes in a patient with supraventricular tachycardia treated by electrical cardioversion. DESIGN: Case report. SETTING: Department of Obstetrics and Gynaecology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital. CASE REPORT: We report a case of electrical cardioversion performed during pregnancy. Young patient with a history of surgical correction of congenital heart defect (double outlet right ventricle, aortic arch hypoplasia and coarctation) with implanted pacemaker for dysfunction of both SA and AV node was diagnosed with persistent atrial flutter leading to incipient heart failure during pregnancy. At 30 weeks of pregnancy, the electrical cardioversion was performed under continuous fetal monitoring. Rest of the pregnancy was uneventful, delivery via caesarean section with obstetric indication (breech presentation, premature rupture of membranes at 37+3/7 weeks) without any complications.


Asunto(s)
Cardioversión Eléctrica , Complicaciones del Embarazo/terapia , Taquicardia Supraventricular/terapia , Adulto , Aleteo Atrial/terapia , Cesárea , Femenino , Cardiopatías Congénitas/cirugía , Insuficiencia Cardíaca/terapia , Humanos , Recién Nacido , Marcapaso Artificial , Complicaciones Posoperatorias/terapia , Embarazo , Tercer Trimestre del Embarazo
4.
Vnitr Lek ; 49(9): 734-9, 2003 Sep.
Artículo en Checo | MEDLINE | ID: mdl-14584425

RESUMEN

Chronic heart failure (CHF) is a very frequent condition. Its frequency increases with prolongation of median life expectancy and due to improvements in medical care. However, medical treatment does not allow adequate control of symptoms in many cases. Therefore, various nonpharmacological approaches are being developed. The so-called biventricular pacing is one of them. Its main goal is to restore impaired mechanical cardiac synchrony that is present in patients with prolonged QRS duration due to inter- or intraventricular conduction abnormality. At present, biventricular pacing can be achieved through positioning of a special pacing lead into a branch of the coronary sinus on the surface of the left ventricle and implanting the other lead into the right ventricular cavity, and the third lead into right atrial appendage. Clinical trials and experience from many centres have documented improvements in clinical status in the vast majority of patients. An improvement in functional classification (NYHA) by at least one class, prolongation of the six minute walk distance by 20-40%, increase the maximal oxygen uptake by 10-40% a beneficial effect on quality of life can be expected. Preliminary results of the COMPANION trial have suggested that cardiac resynchronization therapy is associated with prognostic effect, especially in conjunction with implantable cardioverter-defibrillator.


Asunto(s)
Gasto Cardíaco Bajo/terapia , Estimulación Cardíaca Artificial , Gasto Cardíaco Bajo/complicaciones , Gasto Cardíaco Bajo/fisiopatología , Estimulación Cardíaca Artificial/métodos , Electrocardiografía , Humanos , Marcapaso Artificial , Disfunción Ventricular Izquierda/complicaciones , Disfunción Ventricular Izquierda/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...